Ian D. Fier

Corporate Officer/Principal bei MOMENTA PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profil

Ian D.
Fier is currently the Chief Manufacturing & Program Officer at Momenta Pharmaceuticals, Inc. He previously worked as the Vice President-Clinical Affairs at BioTransplant, Inc. Fier holds an MBA degree from Boston University and an undergraduate degree from Tufts University.

Aktive Positionen von Ian D. Fier

Unternehmen	Position	Beginn
MOMENTA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.10.2002

Alle aktiven Positionen von Ian D. Fier

Ehemalige bekannte Positionen von Ian D. Fier

Unternehmen	Position	Ende
BioTransplant, Inc. BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Ian D. Fier im Detail an

Ausbildung von Ian D. Fier

Tufts University	Undergraduate Degree
Boston University	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ian D. Fier im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology
BioTransplant, Inc. BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.	Health Technology